Briefcase atop a skyline of REITs and infrastructure with a “BUY” ticket—signaling insider conviction, real-asset focus, and earnings leverage.

Cohen & Steers (CNS): Chairman Buys Millions—Time To Clip the Coupon or Clip Your Wings?

CNS shows mid-single-digit revenue growth, double-digit EPS growth, and a fresh $2.85M insider buy. Real-asset optionality, de-foamed multiple, TL;DR + FAQs.

 

Read entire article

CSX locomotive hauling mixed freight across a U.S. map with a “BUY” ticket in the cab—signaling CEO purchase, intermodal growth, and steady cash compounding.

CEO Buys Shares of CSX. Should You Board Or Stay Off-Track?

CEO buy signal, steady margins, and intermodal momentum—yet top line is flat-ish and valuation looks fair. Our fun + smart breakdown with TL;DR & FAQs.

 

Read entire article

Iridium-style LEO satellite beaming coverage to the whole globe with IoT and phone icons—signaling global reach, D2D potential, and investor focus on valuation.

CEO Bought Shares At Twice Today’s Price: Time To Buy Iridium Communications (IRDM)?

CEO bought at ~$37; shares now ~$19. We break down Iridium’s moat, IoT and PNT/D2D bets, valuation reset, and key risks—without the rocket emojis (ok, a few).

 

Read entire article

Arcade coin labeled $PLAY being inserted into a glowing machine, symbolizing investment in Dave & Buster’s stock and a potential comeback.

New CEO Buys In at Dave & Buster’s ($PLAY). Who Doesn’t Like a Little PLAY in Their Portfolio — or Life?

New CEO Tarun Lal takes the reins—and a big slice of $PLAY stock. With insiders buying, institutions overloaded, and sales trends improving, could this be the next comeback classic of the “entertainment” era?

Read entire article

A dynamic stock market-themed digital illustration prominently featuring the stock tickers 'MRNA' and 'CVS' in bold at the center. Surrounding them, various other stock tickers (AMRC, WD, BLMN, ECPG, SEDG, RUN, etc.)

Insider Intel: What CEOs Are Buying (And What They Hope You Won’t Notice)

CEOs and top execs are putting their money where their mouth is—but should you follow their lead? From Moderna's biotech bet to Permian's big energy play, this week's insider moves reveal patterns worth watching. Dive into the details and spot the next market trend before it hits the headlines.

Read entire article